• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于聚乳酸-乙醇酸共聚物的纳米颗粒作为增强癌症免疫治疗的递送系统。

Poly lactic-co-glycolic acid-based nanoparticles as delivery systems for enhanced cancer immunotherapy.

作者信息

Gao Lei, Li Jing, Song Tianhang

机构信息

The Second Hospital of Tianjin Medical University, Tianjin, China.

State Key Laboratory of Elemento-Organic Chemistry, Institute of Elemento-Organic Chemistry, College of Chemistry, Nankai University, Tianjin, China.

出版信息

Front Chem. 2022 Aug 15;10:973666. doi: 10.3389/fchem.2022.973666. eCollection 2022.

DOI:10.3389/fchem.2022.973666
PMID:36046731
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9420966/
Abstract

Cancer has emerged as one of the most severe diseases in modern times, various therapies have advanced remarkably in recent decades. Unlike the direct therapeutic targeting tumor cells, immunotherapy is a promising strategy that stimulate the immune system. In cancer immunotherapy, polymeric-based nanoparticles can serve as deliver systems for antigens and immunostimulatory molecules, and they have attracted increasing attention and revolutionized cancer therapy. Poly (lactic-co-glycolic acid) (PLGA) is the most frequently used clinically approved biodegradable polymer and has a broad scope of modification of its inherent properties. Recent advances in PLGA based drug delivery systems in cancer immunotherapy have been described in this mini review, with special emphasis on cancer vaccines and tumor microenvironment modulation.

摘要

癌症已成为现代最严重的疾病之一,近几十年来各种治疗方法有了显著进展。与直接靶向肿瘤细胞的治疗方法不同,免疫疗法是一种刺激免疫系统的有前景的策略。在癌症免疫疗法中,基于聚合物的纳米颗粒可作为抗原和免疫刺激分子的递送系统,它们已引起越来越多的关注并彻底改变了癌症治疗。聚乳酸-羟基乙酸共聚物(PLGA)是临床上最常用的经批准的可生物降解聚合物,并且对其固有特性具有广泛的修饰范围。本综述介绍了基于PLGA的药物递送系统在癌症免疫疗法中的最新进展,特别强调了癌症疫苗和肿瘤微环境调节。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ca1/9420966/211f2b3eaec1/fchem-10-973666-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ca1/9420966/1fce8eccc7ec/fchem-10-973666-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ca1/9420966/211f2b3eaec1/fchem-10-973666-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ca1/9420966/1fce8eccc7ec/fchem-10-973666-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ca1/9420966/211f2b3eaec1/fchem-10-973666-g002.jpg

相似文献

1
Poly lactic-co-glycolic acid-based nanoparticles as delivery systems for enhanced cancer immunotherapy.基于聚乳酸-乙醇酸共聚物的纳米颗粒作为增强癌症免疫治疗的递送系统。
Front Chem. 2022 Aug 15;10:973666. doi: 10.3389/fchem.2022.973666. eCollection 2022.
2
Poly(lactic acid)-based particulate systems are promising tools for immune modulation.基于聚乳酸的颗粒系统是免疫调节的有前途的工具。
Acta Biomater. 2017 Jan 15;48:41-57. doi: 10.1016/j.actbio.2016.11.012. Epub 2016 Nov 4.
3
Particulate Systems Based on Poly(Lactic-co-Glycolic)Acid (pLGA) for Immunotherapy of Cancer.基于聚乳酸-乙醇酸共聚物(pLGA)的微粒系统用于癌症免疫治疗
Curr Pharm Des. 2015;21(29):4201-16. doi: 10.2174/1381612821666150901100247.
4
Application of PLGA in Tumor Immunotherapy.聚乳酸-羟基乙酸共聚物在肿瘤免疫治疗中的应用。
Polymers (Basel). 2024 Apr 30;16(9):1253. doi: 10.3390/polym16091253.
5
PLGA Particles in Immunotherapy.免疫疗法中的聚乳酸-羟基乙酸共聚物微粒
Pharmaceutics. 2023 Feb 11;15(2):615. doi: 10.3390/pharmaceutics15020615.
6
Polymer-mediated nanoformulations: a promising strategy for cancer immunotherapy.聚合物介导的纳米制剂:癌症免疫治疗的一种有前景的策略。
Naunyn Schmiedebergs Arch Pharmacol. 2024 Mar;397(3):1311-1326. doi: 10.1007/s00210-023-02699-9. Epub 2023 Sep 11.
7
Enhanced stimulation of anti-breast cancer T cells responses by dendritic cells loaded with poly lactic-co-glycolic acid (PLGA) nanoparticle encapsulated tumor antigens.负载聚乳酸-乙醇酸共聚物(PLGA)纳米颗粒包裹肿瘤抗原的树突状细胞增强抗乳腺癌T细胞反应的刺激作用。
J Exp Clin Cancer Res. 2016 Oct 26;35(1):168. doi: 10.1186/s13046-016-0444-6.
8
Poly(lactic acid) and poly(lactic-co-glycolic acid) particles as versatile carrier platforms for vaccine delivery.聚乳酸和聚乳酸-乙醇酸共聚物颗粒作为疫苗递送的多功能载体平台。
Nanomedicine (Lond). 2014 Dec;9(17):2703-18. doi: 10.2217/nnm.14.156.
9
Targeting dendritic cells with nano-particulate PLGA cancer vaccine formulations.用纳米颗粒 PLGA 癌症疫苗制剂靶向树突状细胞。
Adv Drug Deliv Rev. 2011 Sep 10;63(10-11):943-55. doi: 10.1016/j.addr.2011.05.021. Epub 2011 Jun 6.
10
Cationic polymer modified PLGA nanoparticles encapsulating Alhagi honey polysaccharides as a vaccine delivery system for ovalbumin to improve immune responses.阳离子聚合物修饰的 PLGA 纳米粒包载驴乳多糖作为卵清蛋白的疫苗传递系统以改善免疫应答。
Int J Nanomedicine. 2019 May 6;14:3221-3234. doi: 10.2147/IJN.S203072. eCollection 2019.

引用本文的文献

1
Application of Polyglycolic Acid/Poly (Lactic-co-glycolic Acid) in Thread Embedding Acupuncture for Obesity: New Strategies and Challenges.聚乙醇酸/聚(乳酸-乙醇酸共聚物)在埋线针灸治疗肥胖症中的应用:新策略与挑战
Diabetes Metab Syndr Obes. 2025 Jul 5;18:2175-2189. doi: 10.2147/DMSO.S525783. eCollection 2025.
2
Biodegradable Polymers for Application as Robust Immunomodulatory Biomaterial Carrier Systems.用作强大免疫调节生物材料载体系统的可生物降解聚合物。
Small. 2025 Feb 16:e2409422. doi: 10.1002/smll.202409422.
3
Application of nanomaterials in precision treatment of lung cancer.

本文引用的文献

1
PLGA-Based Composites for Various Biomedical Applications.用于各种生物医学应用的基于聚乳酸-羟基乙酸共聚物的复合材料
Int J Mol Sci. 2022 Feb 12;23(4):2034. doi: 10.3390/ijms23042034.
2
Cancer cell membrane-coated nanoparticles for bimodal imaging-guided photothermal therapy and docetaxel-enhanced immunotherapy against cancer.基于细胞膜包覆纳米颗粒的双模成像引导光热治疗及多西紫杉醇增强免疫治疗癌症
J Nanobiotechnology. 2021 Dec 24;19(1):449. doi: 10.1186/s12951-021-01202-x.
3
Intracellular signaling pathway in dendritic cells and antigen transport pathway in vivo mediated by an OVA@DDAB/PLGA nano-vaccine.
纳米材料在肺癌精准治疗中的应用。
iScience. 2024 Dec 26;28(1):111704. doi: 10.1016/j.isci.2024.111704. eCollection 2025 Jan 17.
4
Application of Nanomaterials Targeting Immune Cells in the Treatment of Chronic Inflammation.靶向免疫细胞的纳米材料在慢性炎症治疗中的应用
Int J Nanomedicine. 2024 Dec 25;19:13925-13946. doi: 10.2147/IJN.S497590. eCollection 2024.
5
Tailoring biomaterials for vaccine delivery.为疫苗传递量身定制生物材料。
J Nanobiotechnology. 2024 Aug 12;22(1):480. doi: 10.1186/s12951-024-02758-0.
6
Non-Invasive Vaccines: Challenges in Formulation and Vaccine Adjuvants.非侵入性疫苗:制剂和疫苗佐剂方面的挑战
Pharmaceutics. 2023 Aug 9;15(8):2114. doi: 10.3390/pharmaceutics15082114.
7
Anti-Pyretic, Analgesic, and Anti-Inflammatory Activities of Meloxicam and Curcumin Co-Encapsulated PLGA Nanoparticles in Acute Experimental Models.美洛昔康与姜黄素共包封聚乳酸-羟基乙酸共聚物纳米粒在急性实验模型中的解热、镇痛和抗炎活性
Metabolites. 2023 Aug 10;13(8):935. doi: 10.3390/metabo13080935.
8
Nanomaterials in tumor immunotherapy: new strategies and challenges.肿瘤免疫治疗中的纳米材料:新策略和挑战。
Mol Cancer. 2023 Jun 13;22(1):94. doi: 10.1186/s12943-023-01797-9.
9
Emerging biomaterials for tumor immunotherapy.用于肿瘤免疫治疗的新型生物材料。
Biomater Res. 2023 May 16;27(1):47. doi: 10.1186/s40824-023-00369-8.
10
Cabozantinib-Loaded PLGA Nanoparticles: A Potential Adjuvant Strategy for Surgically Resected High-Risk Non-Metastatic Renal Cell Carcinoma.载卡博替尼 PLGA 纳米粒:一种用于手术切除高危非转移性肾细胞癌的潜在辅助策略。
Int J Mol Sci. 2022 Oct 20;23(20):12634. doi: 10.3390/ijms232012634.
OVA@DDAB/PLGA 纳米疫苗介导的树突状细胞内信号转导途径和体内抗原转运途径。
J Nanobiotechnology. 2021 Nov 27;19(1):394. doi: 10.1186/s12951-021-01116-8.
4
Engineered Nanovaccine Targeting Clec9a Dendritic Cells Remarkably Enhances the Cancer Immunotherapy Effects of STING Agonist.工程化纳米疫苗靶向 Clec9a 树突状细胞显著增强 STING 激动剂的癌症免疫治疗效果。
Nano Lett. 2021 Dec 8;21(23):9939-9950. doi: 10.1021/acs.nanolett.1c03243. Epub 2021 Nov 15.
5
Co-delivery of Phagocytosis Checkpoint Silencer and Stimulator of Interferon Genes Agonist for Synergetic Cancer Immunotherapy.共递送吞噬作用检查点沉默剂和干扰素基因激动剂佐剂以实现协同癌症免疫治疗。
ACS Appl Mater Interfaces. 2021 Jun 30;13(25):29424-29438. doi: 10.1021/acsami.1c08329. Epub 2021 Jun 15.
6
Development of Toll-like Receptor Agonist-Loaded Nanoparticles as Precision Immunotherapy for Reprogramming Tumor-Associated Macrophages.Toll 样受体激动剂负载纳米颗粒的开发作为重新编程肿瘤相关巨噬细胞的精准免疫治疗。
ACS Appl Mater Interfaces. 2021 Jun 2;13(21):24442-24452. doi: 10.1021/acsami.1c01453. Epub 2021 May 19.
7
PLGA-particle vaccine carrying TLR3/RIG-I ligand Riboxxim synergizes with immune checkpoint blockade for effective anti-cancer immunotherapy.携带 TLR3/RIG-I 配体 Riboxxim 的 PLGA 微粒疫苗与免疫检查点阻断联合用于有效的癌症免疫治疗。
Nat Commun. 2021 May 18;12(1):2935. doi: 10.1038/s41467-021-23244-3.
8
Nanoparticles as Smart Carriers for Enhanced Cancer Immunotherapy.作为增强癌症免疫疗法的智能载体的纳米颗粒。
Front Chem. 2020 Dec 21;8:597806. doi: 10.3389/fchem.2020.597806. eCollection 2020.
9
Employing ATP as a New Adjuvant Promotes the Induction of Robust Antitumor Cellular Immunity by a PLGA Nanoparticle Vaccine.采用三磷酸腺苷作为新型佐剂促进 PLGA 纳米颗粒疫苗诱导强大的抗肿瘤细胞免疫。
ACS Appl Mater Interfaces. 2020 Dec 9;12(49):54399-54414. doi: 10.1021/acsami.0c15522. Epub 2020 Nov 20.
10
A Hybrid Eukaryotic-Prokaryotic Nanoplatform with Photothermal Modality for Enhanced Antitumor Vaccination.一种具有光热模式的混合真核-原核纳米平台,用于增强抗肿瘤免疫治疗。
Adv Mater. 2020 Apr;32(16):e1908185. doi: 10.1002/adma.201908185. Epub 2020 Feb 28.